VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
GBLI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
GBLIGlobal Indemnity Group, LLC
$21.75$312M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksGBLIFinancials

Global Indemnity Group, LLC (GBLI) Income Statement

24Y historyFree accessUpdated daily

Revenue returned to modest growth at 5.1% YoY in 2026Q2 while the combined ratio improved to 87.6% from 104.7% in 2025Q1, though the 45.7% loss ratio and near-42% implied expense ratio appear mutually inconsistent across quarters and may indicate reserve-driven distortion rather than stable pricing.

Income StatementBalance SheetCash FlowRatios

GBLI Income Statement

Annual statement

GBLI Income Statement

Global Indemnity Group, LLC (GBLI) annual income statement — 24-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02
Revenue454.94M450.1M441.19M528.13M628.53M678.27M583.55M604.47M498.94M485.51M534.51M538.78M333.75M319.13M293.02M385.02M370.13M387.75M400.08M614.63M612.44M523.1M252.98M205.32M168.75M
Revenue Growth %2.97%2.02%-16.46%-15.97%-7.33%16.23%-3.46%21.15%2.76%-9.17%-0.79%61.43%4.58%8.91%-23.9%4.02%-4.54%-3.08%-34.91%0.36%17.08%106.77%23.21%21.67%-
Medical Costs & Claims248.37M385.09M360.54M471.77M595.61M607.8M551.81M483.81M525.4M452.94M460.65M476.67M247.18M238.64M249.03M400.18M248.57M289.31M447.94M473.42M478.04M432.19M213.63M167.09M220.69M
Medical Cost Ratio %54.59%85.56%81.72%89.33%94.76%89.61%94.56%80.04%105.3%93.29%86.18%88.47%74.06%74.78%84.99%103.94%67.16%74.61%111.96%77.03%78.06%82.62%84.45%81.38%130.78%
Gross Profit206.58M65M80.65M56.36M32.92M70.46M31.74M120.67M-26.46M32.57M73.86M62.11M86.58M80.49M43.98M-15.15M121.55M98.44M-47.86M141.21M134.4M90.91M39.35M38.23M-51.94M
Gross Margin %45.41%14.44%18.28%10.67%5.24%10.39%5.44%19.96%-5.3%6.71%13.82%11.53%25.94%25.22%15.01%-3.94%32.84%25.39%-11.96%22.97%21.94%17.38%15.55%18.62%-30.78%
Gross Profit Growth %--19.4%43.1%71.17%-53.27%122.01%-73.7%555.95%-181.26%-55.9%18.93%-28.26%7.56%83%390.23%-112.47%23.48%305.67%-133.89%5.07%47.84%131.02%2.94%173.6%-
Operating Expenses165.83M31.71M25.7M23.38M30.95M37.66M60.85M38.91M49.46M42.62M26.24M29.36M15.38M17.78M15.08M20.45M27.79M23.97M119.02M23.06M27.91M24.3M-129.51M4.72M49.99M
OpEx / Revenue %36.45%7.04%5.82%4.43%4.92%5.55%10.43%6.44%9.91%8.78%4.91%5.45%4.61%5.57%5.15%5.31%7.51%6.18%29.75%3.75%4.56%4.64%-51.19%2.3%29.62%
Depreciation & Amortization4.68M5.66M5.76M6.2M8.4M10.41M7.03M7.1M7.02M6.5M6.31M5.28M3.47M3.81M2.28M2.22M4.47M73K1.01M1.01M1.74M8.73M3.19M90K0
Combined Ratio %91.04%92.6%87.54%93.76%99.69%95.16%104.99%86.47%115.22%102.07%91.09%93.92%78.67%80.35%90.14%109.25%74.67%80.79%141.71%80.78%82.61%87.27%33.25%83.68%160.4%
Operating Income40.75M33.3M54.96M32.98M1.97M32.8M-29.11M81.76M-75.92M-10.05M47.62M32.75M71.19M62.71M28.9M-35.6M93.77M74.47M-166.89M118.15M106.49M66.61M168.86M33.5M-101.93M
Operating Margin %8.96%7.4%12.46%6.24%0.31%4.84%-4.99%13.53%-15.22%-2.07%8.91%6.08%21.33%19.65%9.86%-9.25%25.33%19.21%-41.71%19.22%17.39%12.73%66.75%16.32%-60.4%
Operating Income Growth %--39.41%66.65%1573.06%-93.99%212.68%-135.61%207.68%-655.47%-121.11%45.42%-54%13.53%116.98%181.17%-137.97%25.91%144.62%-241.25%10.95%59.86%-60.55%404%132.87%-
EBITDA45.44M38.96M60.72M39.17M10.37M43.22M-22.08M88.86M-68.91M-3.54M53.93M38.03M74.66M66.52M31.18M-33.38M98.23M74.54M-165.88M119.16M108.23M75.34M172.05M33.59M-101.82M
EBITDA Margin %9.99%8.66%13.76%7.42%1.65%6.37%-3.78%14.7%-13.81%-0.73%10.09%7.06%22.37%20.84%10.64%-8.67%26.54%19.22%-41.46%19.39%17.67%14.4%68.01%16.36%-60.34%
Interest Expense00003M10.48M15.79M20.02M19.69M16.91M8.9M4.91M822K6.17M5.39M6.48M7.02M7.22M8.66M11.37M11.39M9.44M5.52M1.65M115K
Non-Operating Income0000-3M-10.48M-15.79M-20.02M-19.69M-16.91M-8.9M-4.91M-822K-6.17M-5.39M-6.48M-7.02M-7.22M-8.66M-11.37M-11.39M-9.44M163.34M-1.65M-115K
Pretax Income40.75M33.3M54.96M32.98M1.97M32.8M-29.11M81.76M-75.92M-10.05M47.62M32.75M71.19M62.71M28.9M-35.6M93.77M74.47M-166.89M118.15M106.49M66.61M33.86M33.5M-101.93M
Pretax Margin %8.96%7.4%12.46%6.24%0.31%4.84%-4.99%13.53%-15.22%-2.07%8.91%6.08%21.33%19.65%9.86%-9.25%25.33%19.21%-41.71%19.22%17.39%12.73%13.38%16.32%-60.4%
Income Tax10.1M7.96M11.71M7.55M2.82M3.45M-8.11M11.74M-19.23M-499K-2.25M-8.72M8.34M1.02M-5.86M2.79M8.87M4.31M-29.22M18.68M18.18M2.97M-2M5.18M-40.52M
Effective Tax Rate %24.77%23.92%21.32%22.89%143.13%10.51%27.84%14.36%25.33%4.97%-4.73%-26.64%11.71%1.62%-20.26%-7.83%9.46%5.79%17.51%15.81%17.07%4.46%-5.89%15.47%39.75%
Net Income30.66M25.33M43.24M25.43M-850K29.35M-21.01M70.02M-56.7M-9.55M49.87M41.47M62.86M61.69M34.76M-38.34M84.87M75.44M-141.56M98.92M99.42M65.59M37.05M77.13M-61.66M
Net Margin %6.74%5.63%9.8%4.81%-0.14%4.33%-3.6%11.58%-11.36%-1.97%9.33%7.7%18.83%19.33%11.86%-9.96%22.93%19.46%-35.38%16.09%16.23%12.54%14.64%37.56%-36.54%
Net Income Growth %9.88%-41.41%70.05%3091.65%-102.9%239.74%-130%223.49%-493.61%-119.15%20.25%-34.03%1.89%77.49%190.66%-145.17%12.51%153.29%-243.11%-0.5%51.57%77.05%-51.96%225.07%-
EPS (Diluted)2.121.753.121.83-0.091.97-1.484.88-4.02-0.552.841.692.482.451.30-1.312.802.91-7.745.305.363.582.562.84-9.63
EPS Growth %9.38%-43.91%70.49%2153.87%-104.52%233.11%-130.33%221.39%-630.91%-119.37%68.05%-31.85%1.22%88.46%199.24%-146.79%-3.78%137.6%-246.04%-1.12%49.72%39.84%-9.86%129.49%-
EPS (Basic)-1.753.141.84-0.092.00-1.484.93-4.02-0.552.891.712.502.461.30-1.312.812.92-7.745.345.403.662.622.84-9.63
Diluted Shares Outstanding14.46M14.26M13.71M13.67M14.48M14.66M14.29M14.33M14.09M17.31M17.55M24.51M25.33M25.17M26.75M30.25M30.27M25.88M18.28M18.68M18.58M18.29M14.42M8.19M6.4M

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Loss ratio volatility distorting earnings quality

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Premium Base Rebounds From Runoff

GBLI's revenue contracted sharply through 2024, with YoY declines reaching -25.6% in 2024Q1, before stabilizing and posting 7.6% growth in 2025Q4 and 5.1% in 2026Q2, indicating a possible shift from portfolio runoff to selective re-expansion, according to quarterly financial disclosures.

The revenue trajectory shows two distinct phases: a pronounced contraction through early 2024 where quarterly top line fell from $112.3M to a trough near $108.4M with double-digit negative YoY comparisons, followed by a recovery phase from 2025Q2 onward with consistent positive growth prints. This pattern is more consistent with deliberate portfolio reshaping or non-renewal of unprofitable lines than with market-share loss, though the company has not disclosed the underlying drivers in the supplied data. Investors should monitor whether the 2026 momentum (0.5% then 5.1%) reflects durable new-business production or simply an easier comparison base, since absolute revenue has only returned to roughly 2024 levels rather than establishing new highs.

Combined Ratio Swings Obscure Core Underwriting

GBLI's combined ratio swung from 104.7% in 2025Q1 to 87.6% in 2026Q2, a nearly 17-point swing in underwriting profitability across five quarters, suggesting earnings may depend more on catastrophe timing than stable pricing, based on GBLI's reported figures.

Excluding the two outlier quarters (2025Q1's 104.7% and 2026Q2's 87.6%), the combined ratio has otherwise clustered in a relatively tight 85.8%-94.9% band, which suggests a baseline underwriting operation that generates modest profit but is periodically disrupted by large loss events or favorable reserve movements. The 2026Q2 print of 87.6% is the strongest in the ten-quarter series and is driven almost entirely by the loss ratio collapsing to 45.7%, not by any observable improvement in expense management. This matters for valuation because a P&C carrier whose profitability is dictated by loss-ratio tail events commands a lower multiple than one with demonstrably stable pricing, and the observed dispersion argues against extrapolating the 2026Q2 result into a forward run-rate.

2026Q2 Loss Ratio Collapse Warrants Scrutiny

2026Q2 marks a sharp inflection, with the loss ratio collapsing to 45.7% from 86.7% in the prior quarter and net income jumping to $11.1M from $4.2M, suggesting a possible large reserve release or non-recurring item that investors should verify against GBLI's filings.

A loss ratio of 45.7% on $116.1M of revenue is a dramatic outlier relative to every other quarter in the series, where the loss ratio has never printed below 79.1%. Because claims of $53.0M in 2026Q2 compare to $94.6M in 2026Q1, the magnitude of the decline is difficult to attribute to ordinary underwriting improvement alone and may reflect reserve strengthening in the prior period reversing, an unusual quarter without catastrophe losses, or an accounting reclassification. Symmetrically, 2025Q1's net loss of $4.0M and 104.7% combined ratio appear to be the offsetting downside event. The two quarters bracket an otherwise stable operating picture, so the practical analytical task is to strip out these swings to establish a sustainable mid-cycle combined ratio closer to the 88-92% range.

Expense Ratio Inconsistency Signals Reporting Noise

GBLI's implied expense ratio appears highly erratic, compressing to roughly 6% in 2025Q4 yet expanding to near 42% in 2026Q2, indicating that acquisition costs and operating expenses are not scaling predictably with the ~$110M quarterly revenue base, according to figures derived from GBLI's income statements.

Deriving expense ratio as combined ratio minus loss ratio produces figures that swing from approximately 5.8% (2025Q4) to 8.2% (2026Q1) to 41.9% (2026Q2), a dispersion that is operationally implausible for a carrier of this size without an intervening explanation such as a reinsurance recovery reclassification or a one-time charge flowing through the expense line. This matters because it undermines the reliability of the combined ratio as a like-for-like measure across periods, and it means the strong 2026Q2 headline underwriting result may not represent an efficiency gain at all. Investors should seek segment-level or statutory disclosures to decompose the underwriting expense line before drawing conclusions about the company's cost discipline relative to peers such as Heritage or Palomar, which operate at materially different scale.

Earnings Quality Challenge to Reported Results

An investor challenging GBLI's reported underwriting profitability might note that the implied expense ratio leapt to roughly 42% in 2026Q2 from about 6-8% in prior quarters, an inconsistency suggesting the loss and expense components may be classified differently across periods, based on GBLI's reported figures, warranting further investigation.

The strongest bear case against GBLI's apparent underwriting profitability is that the accounting boundaries between claims, expenses, and investment results are not consistently applied across the ten-quarter window, which makes trend analysis of the combined ratio less informative than it appears. A secondary challenge is that investment income is not disclosed in the supplied data, so the degree to which underwriting profit below 100% actually translates into net income cannot be independently verified from these figures alone. Finally, the peer set includes carriers like Palomar growing revenue at 58% with a 25.5% ROIC, against which GBLI's single-digit or negative revenue growth and episodic loss-quarter volatility suggest a structurally less advantaged franchise, regardless of what the headline combined ratio shows in any individual quarter.

GBLI — Frequently Asked Questions

Quick answers to the most common questions about buying GBLI stock.

What was Global Indemnity Group, LLC's (GBLI) revenue in 2025?

For fiscal year 2025, Global Indemnity Group, LLC (GBLI) reported total revenue of $450.1M. This represents a 166.7% increase compared to $168.7M in 2002.

Is Global Indemnity Group, LLC (GBLI) profitable?

Global Indemnity Group, LLC (GBLI) is profitable, generating $25.3M in net income for the fiscal year ending 2025 with a net profit margin of 5.6%.

What is Global Indemnity Group, LLC's operating profit margin?

Global Indemnity Group, LLC (GBLI) reported an operating income of $33.3M, resulting in an operating profit margin of 7.4%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Global Indemnity Group, LLC's gross profit and gross margin?

Global Indemnity Group, LLC (GBLI) generated $65.0M in gross profit for the year, representing a gross profit margin of 14.4%. This demonstrates the company's core pricing power and production efficiency.